Lantheus Quote - LNTH

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

87.48

Bid

87.45

Ask

87.57

Volume

635,402

85.24 Day's Range 88.52

50.20 52 Week Range 126.8899

Market Cap

6.082B

Previous Close

86.45

Open

86.82

Last Trade

87.4869

Last Trade Time

12:14:38

Financial Volume

US$ 55,390,799

VWAP

87.1744

Average Volume (3m)

903,787

Shares Outstanding

69,526,841

Dividend Yield

PE Ratio

18.65

Earnings Per Share (EPS)

4.7

Revenue

1.3B

Net Profit

326.66M

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in ... Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.lantheus.com

Headquarters

Wilmington, Delaware, USA

Founded

Lantheus Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker LNTH. The last closing price for Lantheus was US$86.45. Over the last year, Lantheus shares have traded in a share price range of US$ 50.20 to US$ 126.8899.

Lantheus currently has 69,526,841 shares outstanding. The market capitalization of Lantheus is US$6.01 billion. Lantheus has a price to earnings ratio (PE ratio) of 18.65.

Overall Flow

Bullish

Net Premium

140k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Form 8-K - Current report

Lantheus Announces Share Repurchase Program

BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Lantheus to Present at the Jefferies London Healthcare Conference

BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...

Form 4 - Statement of changes in beneficial ownership of securities

Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

BEDFORD, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling...

Form 144 - Report of proposed sale of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	6.975	8.66405813304	80.505	88.52	75	1322803	80.91378192	CS
4	-23.325	-21.0504941113	110.805	118.21	75	1473914	91.66876184	CS
12	-23.06	-20.8612267053	110.54	118.21	75	903787	98.84494358	CS
26	4.99	6.04921808704	82.49	126.8899	75	973065	99.66353075	CS
52	18.7	27.1881360861	68.78	126.8899	50.2	1058920	79.9396617	CS
156	58.73	204.27826087	28.75	126.8899	23.51	1066487	70.87469776	CS
260	66.69	320.779220779	20.79	126.8899	8.67	844830	57.77180628	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WORXSCWorx Corporation	US$ 2.18 (122.45%)	121.49M
CRNCCerence Inc	US$ 5.4308 (92.58%)	48.25M
SPAISafe Pro Group Inc	US$ 4.61 (44.06%)	40.56M
QUBTQuantum Computing Inc	US$ 4.9183 (33.65%)	109.66M
PROCProcaps Group SA	US$ 0.75 (31.23%)	48.6k
WCTWellchange Holdings Company Limited	US$ 1.365 (-58.89%)	1.24M
SKKSKK Holdings Limited	US$ 1.885 (-58.66%)	13.43M
PYXSPyxis Oncology Inc	US$ 2.11 (-44.76%)	11.8M
GLXGGalaxy Payroll Group Ltd	US$ 2.26 (-42.20%)	1.9M
TMTCTMT Acquisition Corporation	US$ 3.84 (-40.37%)	37.73k
CDTConduit Pharmaceuticals Inc	US$ 0.1155 (25.14%)	541.08M
NVDANVIDIA Corporation	US$ 144.2492 (-1.12%)	266.05M
AKTSAkoustis Technologies Inc	US$ 0.1024 (17.57%)	194.25M
ELABElevai Labs Inc	US$ 0.0204 (-4.67%)	189.71M
WORXSCWorx Corporation	US$ 2.18 (122.45%)	121.49M